0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Japan Sexually Transmitted Diseases (STDs) Drug Market Research Report 2018
Published Date: March 2019
|
Report Code: QYRE-Othe-09
Home | Market Reports | Health | Reproductive Health
Japan Sexually Transmitted Diseases  STDs Drug Market Research Report 2018

Japan Sexually Transmitted Diseases (STDs) Drug Market Research Report 2018

Code: QYRE-Othe-09
Report
March 2019
97 Pages
QYResearch
Region: Asia Pacific,
Description
Table of Content
Tables & Figures

The global Sexually Transmitted Diseases (STDs) Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

 

Japan plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

 

This report studies the Sexually Transmitted Diseases (STDs) Drug development status and future trend in Japan, focuses on top players in Japan, also splits Sexually Transmitted Diseases (STDs) Drug by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

 

The major players in Japan market include

Pfizer

Hoffmann La Roche

Bayer Healthcare

Eli Lilly

Johnson & Johnson

Bristol-Myers Squibb

AbbVie, Inc.

Gilead Sciences

GlaxoSmithKline Plc

Merck & Co., Inc.

 

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

by Disease Type

Chlamydia

Gonorrhea

Syphilis

Genital herpes

HPV

HIV / AIDS

by Therapy Class

Antibiotics

Antiviral / Antiretrovirals

Vaccines

 

On the basis of the end users/Application, this report covers

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

 
 

 


 
 
 
 

 

 

 

List of Tables and Figures

 

Figure Japan Market Size (Million USD) Status and Outlook (2013-2025)

Table Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Revenue (Million USD) Market Split by Product Type

Table Sexually Transmitted Diseases (STDs) Drug Sales (K Units) by Application (2017-2025)

Figure Product Picture of Sexually Transmitted Diseases (STDs) Drug

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Volume Market Share by Type in 2017

Figure Chlamydia Product Picture

Figure Gonorrhea Product Picture

Figure Syphilis Product Picture

Figure Genital herpes Product Picture

Figure HPV Product Picture

Figure HIV / AIDS Product Picture

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Comparison by Application (2013-2025)

Figure Japan Sales Market Share (%) of Sexually Transmitted Diseases (STDs) Drug by Application in 2017

Figure Hospital Pharmacies Examples

Figure Retail Pharmacies Examples

Figure Online Pharmacies Examples

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales of Key Players/Manufacturers (2013-2018)

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales Share (%) by Players/Manufacturers (2013-2018)

Figure 2017 Japan Sexually Transmitted Diseases (STDs) Drug Sales Share (%) by Players/Manufacturers

Figure 2017 Japan Sexually Transmitted Diseases (STDs) Drug Sales Share (%) by Players/Manufacturers

Table Japan Sexually Transmitted Diseases (STDs) Drug Revenue by Players/Manufacturers (2013-2018)

Table Japan Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)

Figure 2017 Japan Sexually Transmitted Diseases (STDs) Drug Revenue Share (%) by Players/Manufacturers

Figure 2017 Japan Sexually Transmitted Diseases (STDs) Drug Revenue Share (%) by Players/Manufacturers

Table Japan Market Sexually Transmitted Diseases (STDs) Drug Average Price (USD/Unit) of Key Players/Manufacturers (2013-2018)

Figure Japan Market Sexually Transmitted Diseases (STDs) Drug Average Price (USD/Unit) of Key Players/Manufacturers in 2017

Figure Japan Sexually Transmitted Diseases (STDs) Drug Market Share of Top 3 Players/Manufacturers

Figure Japan Sexually Transmitted Diseases (STDs) Drug Market Share of Top 5 Players/Manufacturers

Table Japan Players/Manufacturers Sexually Transmitted Diseases (STDs) Drug Manufacturing Base Distribution and Sales Area

Table Japan Players/Manufacturers Sexually Transmitted Diseases (STDs) Drug Product Category

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) by Type (2013-2018)

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales Share (%) by Type (2013-2018)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Share (%) by Type (2013-2018)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) by Type in 2017

Table Japan Sexually Transmitted Diseases (STDs) Drug Revenue (Million USD) and Market Share by Type (2013-2018)

Table Japan Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) by Type (2013-2018)

Figure Revenue Market Share of Sexually Transmitted Diseases (STDs) Drug by Type (2013-2018)

Figure Revenue Market Share of Sexually Transmitted Diseases (STDs) Drug by Type in 2017

Table Japan Sexually Transmitted Diseases (STDs) Drug Price (USD/Unit) by Type (2013-2018)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (%) by Type (2013-2018)

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) by Application (2013-2018)

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) by Application (2013-2018)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) by Application (2013-2018)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) by Application in 2017

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (%) by Application (2013-2018)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Growth Rate (%) by Application (2013-2018)

Table Pfizer Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Pfizer Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Pfizer Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Pfizer Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Pfizer Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Eli Lilly Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Eli Lilly Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure AbbVie, Inc. Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Basic Information List

Table Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)

Figure Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%)(2013-2018)

Figure Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Sales Market Share (%) in Japan (2013-2018)

Figure Merck & Co., Inc. Sexually Transmitted Diseases (STDs) Drug Revenue Market Share (%) in Japan (2013-2018)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Sexually Transmitted Diseases (STDs) Drug

Figure Manufacturing Process Analysis of Sexually Transmitted Diseases (STDs) Drug

Figure Sexually Transmitted Diseases (STDs) Drug Industrial Chain Analysis

Table Raw Materials Sources of Sexually Transmitted Diseases (STDs) Drug Major Players/Manufacturers in 2017

Table Major Buyers of Sexually Transmitted Diseases (STDs) Drug

Table Distributors/Traders List

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) and Growth Rate (%) Forecast (2018-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Price (USD/Unit) Trend Forecast (2018-2025)

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Forecast by Type (2018-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Forecast by Type (2018-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Volume Market Share Forecast by Type in 2025

Table Japan Sexually Transmitted Diseases (STDs) Drug Sales (K Units) Forecast by Application (2018-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Volume Market Share Forecast by Application (2018-2025)

Figure Japan Sexually Transmitted Diseases (STDs) Drug Sales Volume Market Share Forecast by Application in 2025

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user to access the PDF.

Electronic (PDF)
$6800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension

RELATED REPORTS

China Aspiration Biopsy Needle Market Report Forecast 2021 2027
China Aspiration & Biopsy Needle Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-24C5124
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

Global and United States Prenatal Education Instrument Market Insights Forecast to 2027
Global and United States Prenatal Education Instrument Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7D3408
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and China Maternity Color Ultrasound Diagnostic Equipment Market Insights Forecast to 2027
Global and China Maternity Color Ultrasound Diagnostic Equipment Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10R3375
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and China Pregnant Women Underwear Market Insights Forecast to 2027
Global and China Pregnant Women Underwear Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10E3374
Thu Sep 23 00:00:00 UTC 2021

Add to Cart